全文获取类型
收费全文 | 93896篇 |
免费 | 354篇 |
国内免费 | 886篇 |
专业分类
95136篇 |
出版年
2023年 | 12篇 |
2022年 | 10篇 |
2021年 | 20篇 |
2020年 | 13篇 |
2019年 | 15篇 |
2018年 | 11849篇 |
2017年 | 10682篇 |
2016年 | 7460篇 |
2015年 | 611篇 |
2014年 | 304篇 |
2013年 | 315篇 |
2012年 | 4245篇 |
2011年 | 12842篇 |
2010年 | 12026篇 |
2009年 | 8244篇 |
2008年 | 9812篇 |
2007年 | 11381篇 |
2006年 | 275篇 |
2005年 | 534篇 |
2004年 | 988篇 |
2003年 | 1040篇 |
2002年 | 798篇 |
2001年 | 279篇 |
2000年 | 179篇 |
1999年 | 41篇 |
1998年 | 22篇 |
1997年 | 30篇 |
1996年 | 10篇 |
1994年 | 12篇 |
1993年 | 34篇 |
1992年 | 44篇 |
1991年 | 58篇 |
1990年 | 18篇 |
1989年 | 23篇 |
1988年 | 31篇 |
1987年 | 25篇 |
1986年 | 18篇 |
1984年 | 21篇 |
1983年 | 32篇 |
1982年 | 15篇 |
1980年 | 12篇 |
1975年 | 13篇 |
1972年 | 258篇 |
1971年 | 285篇 |
1970年 | 18篇 |
1968年 | 9篇 |
1965年 | 15篇 |
1962年 | 28篇 |
1944年 | 12篇 |
1940年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
AVRAM HERSHKO PIERRE MAMONT ROBERT SHIELDS GORDON M. TOMKINS 《Nature: New biology》1971,232(33):206-211
A hypothesis has been developed to relate stringent control in bacteria to a set of interactions involved in the regulation of growth of transformed and untransformed mammalian cells. 相似文献
72.
Kimball and Wilson1 reported that the arabinose analogue of cytidine (ara-C) inhibited DNA polymerase in a crude extract prepared from Ehrlich ascites cells. Furth and Cohen2 observed cytosine arabinoside triphosphate (ara-CTP) inhibited DNA polymerase in extracts from either calf thymus or bovine lymphosarcoma tissue, although these investigators3 had already found no effect of ara-CTP on DNA polymerase from Escherichia coli. The inhibition in both of these cases could be substantially reversed by dCTP; but incorporation of the arabinose nucleotide (ara-CMP) into DNA could not be unequivocally demonstrated. Graham and Whitmore4 reported the incorporation of ara-C into DNA in vivo and the inhibition of a DNA polymerase from L cells by ara-CTP. They found that ara-CMP was initially incorporated into small DNA strands but subsequently appeared in long strands. Momparler5 has presented evidence that, in vitro, ara-C incorporation was limited to the 3′-hydroxyl end of DNA chains. Such incorporation might be expected to block further chain elongation but this expectation was not supported by the evidence presented by Graham and Whitmore. 相似文献
73.
ALINA TAYLOR 《Nature: New biology》1971,234(48):144-145
JACOB and Fuerst1,2 demonstrated the presence of a bacteriolytic enzyme (λ-endolysin) in the induced cultures of lysogenic Escherichia coli K12 (λ). The enzyme was later identified as the product of gene R; of phage λ3 which is involved in bacterial lysis at the end of a latent period. The enzyme is apt to form spheroplast-like structures in E. coli2 and one would therefore expect its substrate to be murein. 相似文献
74.
75.
Paula Tatiana Lopes Seixas Antonio Jacinto Demuner Luiz Claudio Almeida Barbosa Cristiane Isaac Cerceau Daiane Einhardt Blank Marcelo Henrique Dos Santos Elizeu de Sá Farias Marcelo Coutinho Picanço 《Journal of Applied Entomology》2023,147(2):116-125
Aedes aegypti L. (Diptera: Culicidae) is a vector for serious diseases in tropical regions. This pest is mainly controlled by commercial larvicides but the application of such products has led to environmental problems. Essential oils (EO) have been consistently reported as molecules with insecticidal activity and can be used to produce more environmentally friendly larvicides in the control of A. aegypti. In this study, the larvicidal effect of essential oils (EO) from the leaves of three Artemisia species was evaluated against A. aegypti. The oils were obtained from steam distillation and their chemical composition was determined by gas chromatography–mass spectrometry. The EO of Artemisia camphorata was the most active in the screening bioassay and presented LC50 and LC95 of 64.95 and 74.18 μg ml−1, respectively. In addition, we found that germacrene D-4-ol was the constituent responsible for the toxicity of this EO. Artemisia camphorata EO and its major constituent, germacrene D-4-ol, are promising for the development of natural larvicides against A. aegypti. 相似文献
76.
77.
Richard L. Atkinson Roy C. Blank Donald Schumacher Nikhil V. Dhurandhar Douglas L. Ritch Eric Chan Thomas S. Rieg 《Obesity (Silver Spring, Md.)》1997,5(6):578-586
ATKINSON, RICHARD L, ROY C BLANK, DONALD SCHUMACHER, NIKHIL V DHURANDHAR, DOUGLAS L RITCH. Long-term drug treatment of obesity in a private practice setting. This study evaluated the long-term efficacy and safety of the combination of phentermine and fenfluramine for the treatment of obesity in a private practice setting. A total of 1388 consecutive, qualified patients presenting to a private general internal medicine practice in Charlotte, NC, were enrolled with eligibility criteria including: age 18 years to 60 years, 20% over “desirable” bodyweight or body mass index <27, no serious medical or psychiatric disease, and no contraindications to drug therapy. Patients were instructed in diet, exercise, and behavior modification techniques and received phentermine (15 mg/day to 30 mg/day) and fenfluramine (20 mg/day to 60 mg/day) continuously for over 3 years. Average duration of treatment was 15. 9 months, and average weight loss at the last visit was 11. 6 kg, or 11. 7% of initial bodyweight. For patients completing 1 year of drug treatment, mean weight loss was 16. 5 kg, or 16% of initial weight. Weight loss persisted for 2 years, but partial regain was seen at 3 years. The dropout rates were 18% at 6 months, 39% at 1 year, 68% at 2 years, and 78% at 3 years. At 1 year, blood pressure of hypertensive patients fell from 151/95 mm Hg to 127/78 mm Hg, and serum cholesterol and triglycerides of hyperlipidemic patients fell by 0. 750 mmol/L (29 mg/dL) and 0. 937 mmol/L (83 mg/dL), respectively. Adverse events were modest. We conclude that, in a private practice setting, long-term treatment of obesity with the combination of phentermine, fenfluramine, and a weight maintenance program is generally safe and effective. More research is needed to determine efficacy and safety for longer than 3 years. 相似文献
78.
The gonadotropin-like activity (GnLa) of serum from pregnant rats was measured using the rat interstitial cell testosterone (RICT) bioassay. Serum GnLA was elevated on day 9 of pregnancy, peaked at 7.2 μg rat LH-RPl equivalents/ml on day 11 and declined to undetectable levels by day 15. Serum LH, measured by homologous RIA, was consistently low (<20 ng/ml) during pregnancy, except near term.Rat placental lactogen (rPL), which was measured in the same serum samples by rat radioreceptor assay (RRA), reached maximal concentrations on days 12 and 13 of pregnancy.These data suggest the presence in pregnancy serum of a potent-gonadotropin-like hormone, different from pituitary LH, whose origin is unknown. Furthermore, there are discrepancies between the times of appearance of this GnLA and rPL. 相似文献
79.
Iu E Dubrova I K Dambueva O N Kholod V D Prokhorovskaia E I Pushkina M L Blank 《Genetika》1991,27(12):2157-2165
80.
M L Blank 《Genetika》1991,27(12):2166-2167
Relationships between heterozygosity of 13 polymorphic loci and variation of the set of anthropometric traits were studied in 302 singleton newborns (174 boys, 128 girls). Statistically significant correlation between heterozygosity and all traits were not found. Variances of four traits--body weight, body length, circumference of head and breast measured by first principal component decrease with increase of heterozygosity in boys and girls. At the same time, variance of body proportions (second principal component) increase significantly in boys only. The highest values of correlation between four traits were found in the group of low heterozygous boys. The groups of newborns with different level of heterozygosity are characterized by different combinations of first principal component and the number of minor deviations from development (stigma). It is concluded from the whole set of data that newborn boys with the average level of heterozygosity have the highest level of viability. 相似文献